Clinical Trials Logo

Advanced Thymic Epithelial Tumor clinical trials

View clinical trials related to Advanced Thymic Epithelial Tumor.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03193437 Terminated - Thymoma Clinical Trials

Selinexor in Patients With Advanced Thymic Epithelial Tumor Progressing After Primary Chemotherapy

SELECT
Start date: April 3, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability and effectiveness of selinexor in patients with advanced thymic epithelial tumor progressing after primary chemotherapy. This is a multicenter, open label phase II trial that uses a Simons two stage design. The study population is adults with histologically confirmed, advanced, inoperable TETs who are progressing after treatment with at least one platinum containing chemotherapy regimen. This study is comprised of 2 similar phase II trials, one running in US (25 patients) and one running in EU (25 patients): There are two study arms: Arm A: Thymoma - Stage 1: 15 patients - Stage 2: 10 patients Arm B: Thymic carcinoma - Stage 1: 15 patients - Stage 2: 10 patients